Published in Stroke on January 19, 1980
Nervous system involvement in association with vasculitis and anticardiolipin antibodies in a patient with systemic sclerosis. Ann Rheum Dis (1994) 0.79
Acute cerebral vasculopathy in systemic sclerosis. Rheumatol Int (2012) 0.76
Progressive systemic sclerosis with CNS vasculitis and cyclosporin A therapy. J Neurol Neurosurg Psychiatry (1993) 0.75
Systemic sclerosis associated with colliquative necrosis in the cerebellum. Surg Neurol Int (2017) 0.75
Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med (1966) 5.26
Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med (1980) 4.90
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg (1978) 4.55
Serological analysis of cell surface antigens of malignant human brain tumors. Proc Natl Acad Sci U S A (1978) 3.99
A prognostic score for patients with lower risk myelodysplastic syndrome. Leukemia (2007) 3.45
Impact of dengue/dengue hemorrhagic fever on the developing world. Adv Virus Res (1999) 3.29
Cryoglobulinemia--a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. Am J Med (1966) 3.15
Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med (1980) 2.87
Astigmatism and myopia in keratoconus. Trans Am Ophthalmol Soc (1972) 2.81
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse. J Clin Oncol (2001) 2.71
Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Leukemia (2003) 2.60
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood (2000) 2.53
Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol (1987) 2.22
Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia. J Clin Invest (2001) 2.21
The benign course of cavernous carotid artery aneurysms. J Neurosurg (1992) 2.15
Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy. N Engl J Med (1994) 2.09
Ocular hypertelorism and pseudohypertelorism. Advances in surgical treatment. Plast Reconstr Surg (1970) 2.01
Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia. Blood (1992) 2.00
The role of the regulatory enzymes of catecholamine synthesis in Parkinson's disease. Neurology (1992) 1.99
Efficacy of methylprednisolone in acute spinal cord injury. JAMA (1984) 1.99
Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. Blood (1998) 1.91
Therapeutic response in phase I trials of antineoplastic agents. Cancer Treat Rep (1986) 1.91
Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep (1983) 1.81
Dementia in Parkinson Disease. Ann Neurol (1979) 1.76
Myelodysplastic syndrome following successful therapy of acute promyelocytic leukemia. Leukemia (1997) 1.73
Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg (1989) 1.72
Molecular epidemiology of a large outbreak of hepatitis B linked to autohaemotherapy. Lancet (2000) 1.66
Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet (2005) 1.63
Recruiting and retaining low-income Latinos in psychotherapy research. J Consult Clin Psychol (1996) 1.62
Clinical and pathological study of 24 cases of gliosarcoma. J Neurosurg (1976) 1.62
Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood (1999) 1.57
Problematic WHO reclassification of myelodysplastic syndromes. Members of the International MDS Study Group. J Clin Oncol (2000) 1.53
A survey of the attitudes of chronic psychiatric patients living in the community toward their medication. Acta Psychiatr Scand (1997) 1.51
Free radicals in cerebral ischemia. Stroke (1978) 1.48
Brain abscess due to Actinobacillus actinomycetemcomitans. Neurology (1967) 1.48
Inflammatory reaction to synthetic dural substitute. Case report. J Neurosurg (1989) 1.45
Preliminary experience with ultrasonic aspiration in neurosurgery. Neurosurgery (1979) 1.45
The N370S mutation in the glucocerebrosidase gene of Portuguese type 1 Gaucher patients: linkage to the PvuII polymorphism. J Inherit Metab Dis (1994) 1.45
Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemia. Leukemia (2005) 1.44
Neuro-ophthalmological assessment of vision before and after radiation therapy alone for pituitary macroadenomas. J Neurosurg (1990) 1.43
Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemia. Am J Med (1992) 1.41
Transvascular treatment of giant aneurysms of the cavernous carotid and vertebral arteries. Functional investigation and embolization. Surg Neurol (1984) 1.40
An algorithm for the management of Parkinson's disease. Neurology (1994) 1.40
The role of intracranial surgery for the treatment of malignant gliomas. Semin Oncol (1986) 1.39
Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy. J Clin Oncol (1993) 1.38
Rabies control in the Republic of the Philippines: benefits and costs of elimination. Vaccine (1991) 1.37
Responses to smoking-related stimuli and early relapse to smoking. Addict Behav (1989) 1.36
The cost of rabies postexposure prophylaxis: one state's experience. Public Health Rep (1998) 1.32
III. Discission of the Pleura in the Treatment of Chronic Empyema. Ann Surg (1906) 1.31
Visual scanning training effect on reading-related tasks in acquired right brain damage. Arch Phys Med Rehabil (1977) 1.29
An extraordinary form of confabulation. Neurology (1978) 1.28
Treatment and survival of low-grade astrocytoma in adults--1977-1988. Neurosurgery (1992) 1.27
Experimental hydrocephalus. Changes in cerebrospinal fluid dynamics as a function of time. Arch Neurol (1972) 1.25
Cerebrospinal fluid production and histological observations in animals with experimental obstructive hydrocephalus. Exp Neurol (1969) 1.25
Subtemporal craniectomy for recurrent shunt obstruction secondary to small ventricles. J Neurosurg (1974) 1.25
Normal range values for thromboelastography in healthy adult volunteers. Braz J Med Biol Res (2009) 1.24
Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature. J Clin Oncol (1993) 1.23
Control of schistosomiasis mansoni in a small north east Brazilian community. Trans R Soc Trop Med Hyg (1971) 1.23
Central nervous system gangliogliomas. Part 2: Clinical outcome. J Neurosurg (1993) 1.22
Branchial pouch sinus tract from the piriform fossa causing acute suppurative thyroiditis, neck abscess, or both: CT appearance and the use of air as a contrast agent. AJR Am J Roentgenol (1996) 1.20
Perceptual remediation in patients with right brain damage: a comprehensive program. Arch Phys Med Rehabil (1985) 1.19
Training sensory awareness and spatial organization in people with right brain damage. Arch Phys Med Rehabil (1979) 1.17
Serum complement levels in patients with mixed (IgM-IgG) cryoglobulinaemia. Clin Exp Immunol (1966) 1.17
Huntington's chorea associated with normal pressure hydrocephalus. Eur Neurol (1975) 1.17
Coincidental pituitary adenoma and cerebral aneurysm with pathological findings. Surg Neurol (1983) 1.17
A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute myelogenous leukemia. Blood (1996) 1.17
Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin Cancer Res (1996) 1.17
Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS). J Am Acad Dermatol (1987) 1.17
Transthoracic removal of thoracic disc. Report of three cases. J Neurosurg (1969) 1.16
Studies on the antiparkinsonism efficacy of lergotrile. Neurology (1975) 1.16
Visual system abnormalities in patients with Parkinson's disease. Arch Neurol (1982) 1.15
Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin). Leukemia (2002) 1.14
Gaucher disease: N370S glucocerebrosidase gene frequency in the Portuguese population. Clin Genet (1994) 1.14
Neonatal hydrocephalus treated by compressive head wrapping. Lancet (1973) 1.12
Visual recovery after transsphenoidal removal of pituitary adenomas. Neurosurgery (1985) 1.11
Hemicraniectomy in the treatment of acute subdural hematoma: a re-appraisal. Surg Neurol (1976) 1.11
Molecular pathways and related target therapies in liver carcinoma. Curr Pharm Des (2007) 1.11
Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL). Leukemia (2002) 1.10
Role of computerized axial tomography in diagnosis, treatment and follow-up of hydrocephalus. Preliminary communication. Childs Brain (1977) 1.10
Implications of potential cure in acute myelogenous leukemia: development of subsequent cancer and return to work. Blood (1997) 1.10
Androgen receptor mutation in Kennedy's disease. Philos Trans R Soc Lond B Biol Sci (1999) 1.09
Reduced virulence of rifampicin-resistant mutants of Francisella tularensis. J Infect Dis (1994) 1.09
Hearing preservation in cerebellopontine angle tumor surgery: the NYU experience 1974-1991. Am J Otol (1993) 1.08
The prognostic impact of BCL2 protein expression in acute myelogenous leukemia varies with cytogenetics. Clin Cancer Res (1999) 1.08
Hemicraniectomy in the management of acute subdural hematoma. J Neurosurg (1971) 1.08
Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes. Leukemia (1995) 1.08
Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy. Cancer Res (1987) 1.08
Remifentanil for cesarean section under general anesthesia: effects on maternal stress hormone secretion and neonatal well-being: a randomized trial. Int J Obstet Anesth (2008) 1.08
Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma. Gut (1996) 1.07
Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long- term survival. Leuk Lymphoma (2001) 1.06
Improved long term survival after intracavitary interleukin-2 and lymphokine-activated killer cells for adults with recurrent malignant glioma. Cancer (1995) 1.06
Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions. Blood (1996) 1.06
Methanol induction optimization for scFv antibody fragment production in Pichia pastoris. Biotechnol Bioeng (2004) 1.06
Light and electron microscopic studies of experimental hydrocephalus. Ependymal and subependymal areas. Acta Neuropathol (1972) 1.05
Ruptured intracranial aneurysms. Case morbidity and mortality. J Neurosurg (1977) 1.05
HEMORRHAGE FROM AN ANEURISM OF THE INTERNAL CAROTID ARTERY, FOLLOWING SEPTIC SORE THROAT. Ann Surg (1918) 1.05